US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Synergy Pharmaceuticals

0.0300

0.0000

Volume:- -

Turnover:- -

Market Cap:7.44M

PE:-0.05

High:0.0300

Open:0.0300

Low:0.0300

Close:0.0300

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Synergy Pharmaceuticals

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.synergypharma.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. Its lead product is plecanatide, a novel uroguanylin based gastrointestinal platform that is traded under the TRULANCE name for the treatment of chronic idiopathic constipation and irritable bowel syndrome. The company also develops dolcanatide to treat mild-to-moderate ulcerative colitis. It has a licensing agreement with Cipher Pharmaceuticals Inc. to develop, market, distribute, and sell TRULANCE in Canada. Synergy Pharmaceuticals Inc. is headquartered in New York, New York. On December 12, 2018, Synergy Pharmaceuticals Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SGYP/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGYP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGYP\",,,,,undefined,":{"symbol":"SGYP","market":"US","secType":"STK","nameCN":"Synergy Pharmaceuticals","latestPrice":0.03,"timestamp":1552680000000,"preClose":0.03,"halted":0,"volume":0,"delay":0,"floatShares":247204738,"shares":248037301,"eps":-0.561684,"marketStatus":"Pre-Mkt","change":0,"latestTime":"05-13 04:39:38 EDT","open":0.03,"high":0.03,"low":0.03,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.561684,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1747143000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.03,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGYP\",,,,,undefined,":{"symbol":"SGYP","floatShares":247204738,"roa":"--","roe":"--","lyrEps":-0.995115,"shares":248037301,"dividePrice":0,"high":0.03,"amplitude":0,"preClose":0.03,"low":0.03,"week52Low":0.03,"pbRate":"-0.08","week52High":2.235,"institutionHeld":0,"latestPrice":0.03,"eps":-0.561684,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.561684,"open":0.03,"prevYearClose":0.03},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.synergypharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0346},{"period":"1month","weight":0.0919},{"period":"3month","weight":-0.0369},{"period":"6month","weight":-0.0238},{"period":"1year","weight":0.1193},{"period":"ytd","weight":-0.0053}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies to treat gastrointestinal diseases and disorders. Its lead product is plecanatide, a novel uroguanylin based gastrointestinal platform that is traded under the TRULANCE name for the treatment of chronic idiopathic constipation and irritable bowel syndrome. The company also develops dolcanatide to treat mild-to-moderate ulcerative colitis. It has a licensing agreement with Cipher Pharmaceuticals Inc. to develop, market, distribute, and sell TRULANCE in Canada. Synergy Pharmaceuticals Inc. is headquartered in New York, New York. On December 12, 2018, Synergy Pharmaceuticals Inc. along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.","exchange":"NASDAQ","name":"Synergy Pharmaceuticals","nameEN":"Synergy Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SGYP\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGYP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-11-08","symbol":"SGYP","fiscalQuarterEnding":"2018/09","expectedEps":-0.13,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2018-08-07","symbol":"SGYP","fiscalQuarterEnding":"2018/06","expectedEps":-0.17,"name":null,"time":"","type":"earning","dateTimestamp":1533614400000,"reportTimeType":"","actualEps":-0.12},{"market":"US","date":"2018-05-10","symbol":"SGYP","fiscalQuarterEnding":"2018/03","expectedEps":-0.17,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"post","actualEps":-0.15},{"market":"US","date":"2018-03-01","symbol":"SGYP","fiscalQuarterEnding":"2017/12","expectedEps":-0.19,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1519880400000,"reportTimeType":"post","actualEps":-0.18},{"market":"US","date":"2017-11-09","symbol":"SGYP","fiscalQuarterEnding":"2017/09","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1510203600000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGYP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGYP\",market:\"US\",delay:false,,,undefined,":{}}}